Royal Bank of Canada raised its price objective for Axsome Therapeutics stock.
1 report, 1 independent
Updated Jun 11
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Royal Bank of Canada raised its price objective for Axsome Therapeutics stock.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Axsome Therapeutics
American biopharmaceutical company
Nothing else this week.
-
Royal Bank of Canada
financial institution in Canada
Related events
- Royal Bank of Canada lifted its price objective for GrafTech International on November 1, 2026.
- Financial firms, including RBC, TD Cowen, Leerink Partners, and Morgan Stanley, raised price targets and provided coverage for Vertex Pharmaceuticals.
- Royal Bank of Canada lifted its target price for Ashanti.
- Royal Bank of Canada upped a stock price objective while McKinley purchased a new stake in Ameriprise Financial.
- Royal Bank of Canada raised its price target for TMX Group.